Skip to content

Schering-Plough SGP Total Current Liabilities

Total Current Liabilities at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$57.72B+1.4%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$5.11B+43.2%
Glaukos logo
GlaukosGKOS
$89.42M+30.5%
AbbVie logo
AbbVieABBV
$42.1B+15.6%
Bausch + Lomb logo
Bausch + LombBLCO
$1.82B+5.4%
HRO
HarrowHROW
$91.44M-51.1%

Other financials

Income statement

See full
Operating income-$15.4M-108%
Net income-$13.8M-56.6%
EPS (diluted)-$0.69+82.6%

Balance sheet

See full
Cash & equivalents$238.9M+312%
Total debt$1.6M
Total equity$250.1M+463%
Total assets$258.4M

Cash flow

See full
Operating cash flow-$13.5M-65.2%
CapEx$676.0K+312%
Free cash flow-$14.2M-70.0%

Valuation

See full
Market cap$744.23M-23.4%
Enterprise value$506.93M

Returns & leverage

See full
Return on equity-34.3%
Debt / equity
Current ratio38×

Where this comes from

Reported directly by Schering-Plough in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The official record: Schering-Plough’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Schering-Plough's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Schering-Plough's total current liabilities?
Schering-Plough (SGP) reported total current liabilities of $6.67M in Q1 2026.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.